XQF-31044-85947
1 vaccination
1 coded response
7 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 786 / TX
- Registered
- 2021-03-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-12
Registered in v-safe
-
2021-03-12
Dose 1 — Moderna
- 2021-03-12
-
2021-03-13
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
-
2021-03-14
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-15
- 2021-03-26
- 2021-04-02
-
2022-03-15
Survey response — 12 months, dose 1MedDRA: Irritable bowel syndrome — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: IBS startedMedDRA releases: 2024-11 · check-in free text available
-
2022-03-15
Report sent to call center — 12 months, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-03-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-12 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-03-15 | Unsuccessful |
Free text
Release 11 — 12 months, dose 1
Symptoms: IBS started
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Irritable bowel syndrome | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release